Our previous study revealed that Shp2 expression is higher in tumor tissues in lung cancer patients with chemotherapy resistance than in controls, indicating that Shp2 is associated with resistance to lung cancer chemotherapy [6]. This evidence concerns the gene PTPN11 and neoplasm.